Essex Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-13,365
| Closed | -$1.17M | – | 479 |
|
|
2018
Q3 | $1.17M | Buy |
+13,365
| New | +$1.17M | 0.14% | 207 |
|
|
2016
Q1 | – | Sell |
-7,244
| Closed | -$682K | – | 313 |
|
|
2015
Q4 | $682K | Sell |
7,244
-11,000
| -60% | -$1.04M | 0.11% | 206 |
|
|
2015
Q3 | $1.47M | Buy |
18,244
+11,000
| +152% | +$884K | 0.24% | 94 |
|
|
2015
Q2 | $868K | Sell |
7,244
-580
| -7% | -$69.5K | 0.13% | 174 |
|
|
2015
Q1 | $817K | Buy |
7,824
+3,816
| +95% | +$398K | 0.11% | 183 |
|
|
2014
Q4 | $389K | Sell |
4,008
-669
| -14% | -$64.9K | 0.06% | 255 |
|
|
2014
Q3 | $365K | Buy |
4,677
+1,516
| +48% | +$118K | 0.06% | 266 |
|
|
2014
Q2 | $200K | Hold |
3,161
| – | – | 0.03% | 334 |
|
|
2014
Q1 | $212K | Sell |
3,161
-1,188
| -27% | -$79.7K | 0.03% | 324 |
|
|
2013
Q4 | $280K | Buy |
4,349
+1,188
| +38% | +$76.5K | 0.04% | 322 |
|
|
2013
Q3 | $202K | Buy |
+3,161
| New | +$202K | 0.03% | 338 |
|